Clinical Trials List
2023-05-10 - 2025-04-30
Phase II
Recruiting6
Terminated1
ICD-10C40.80
Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb
ICD-10C40.81
Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb
ICD-10C40.82
Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb
ICD-10C40.90
Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb
ICD-10C40.91
Malignant neoplasm of unspecified bones and articular cartilage of right limb
ICD-10C40.92
Malignant neoplasm of unspecified bones and articular cartilage of left limb
ICD-10C41.9
Malignant neoplasm of bone and articular cartilage, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9170.9
Malignant neoplasm of bone and articular cartilage, site unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Jen-Shi Chen Division of Hematology & Oncology
- 徐執中 Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- 余紹銘 Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Cheng-I Hsieh Division of Hematology & Oncology
- MING-CHE LIU Division of Hematology & Oncology
- Huan-Tze Lin Division of Hematology & Oncology
- Sheng-Yu Chen Division of Hematology & Oncology
- 陳瑩盈 Division of Hematology & Oncology
- CHIN-SHENG HUNG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉瑛珠 Division of Hematology & Oncology
- 林瑛珠 Division of Hematology & Oncology
- 游介宇 Division of Hematology & Oncology
- 溫武慶 Division of Hematology & Oncology
- 柯卉玲 Division of Hematology & Oncology
- 季懋欣 Division of Hematology & Oncology
- 林士森 Division of Hematology & Oncology
- 楊凱琳 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林哲斌 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳敬炫 Division of Hematology & Oncology
- Ta-Chih Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳敬炫 Division of Hematology & Oncology
- Ta-Chih Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
75 participants
-
Global
150 participants
